NVIDIA Extends Recovery, but the Street Is Getting Selective on Price

Options positioning has normalised fully from the panic extreme flagged in the mid-September note. The put/call ratio now reads 0.88, slightly below its 20-day average of 0.91, and the z-score is a mild -0.41. Two weeks ago that same ratio was sitting at 1.10, a full-year high and 2.7 standard deviations above trend. The complete unwinding of that defensive hedge tells you the investors who rushed to buy downside protection into the dip have now stood down. The lending market adds nothing of note: short interest is just 1.2% of free float, down modestly on the week and month, borrow cost has fallen 27% over the week to a near-frictionless 0.17%, and availability is essentially unconstrained. There is no short-side pressure worth discussing.

The analyst debate is where the texture lies, and it is more nuanced than the headline "buy" consensus suggests. Following the August 26 earnings beat — when the stock jumped 7% in a single session — a wave of target upgrades rolled in. Bernstein raised its target to $400, JP Morgan moved to $320 from $280, and RBC, Mizuho, Citigroup, and Oppenheimer all lifted targets into the $300–$330 range. Piper Sandler then initiated at Overweight with a $300 target on September 10. The current stock price of $228.87 implies meaningful upside to almost every target on the Street. The bull case centres on NVIDIA's AI ecosystem expansion — including its acquisition of Hugging Face — and continued data centre dominance. Bears flag gross margin pressure, slowing GPU proliferation, and the risk of excessive reliance on a single segment. What's notable is that even the bulls are clustering targets in a $300–$330 band rather than chasing the Bernstein $400 outlier, which suggests the Street's conviction has a ceiling. A PE near 16x and EV/EBITDA around 13.7x on current estimates are not stretched for a franchise of this quality, but the forward EPS growth comparison — with a 30-day EPS momentum factor score in the 94th percentile yet a forward year-on-year EPS increase rank near the bottom quartile — shows that the easy part of the earnings upgrade cycle may already be priced.

Insider activity is the one angle that adds friction to an otherwise clean bullish read. Director Mark Stevens sold approximately $300 million worth of shares on September 18 in open-market transactions — not under a pre-arranged 10b5-1 plan. CFO Colette Kress sold a further $7.6 million across two tranches on September 17, though those sales were plan-governed and carry less signal. CEO Jensen Huang filed a gift of 438,000 shares the same day, a transaction code that tells you nothing about conviction. The Stevens sale is the one to note: it is large, it is discretionary, and it landed while the stock was still recovering from its mid-September trough. It does not change the fundamental picture, but a $300 million open-market disposal from a board member is worth tracking against where the stock goes into November.

The short score has been pinned in a remarkably tight band — ranging from 29.6 to 29.9 across the past two weeks — reflecting a stock where the short-side data is simply not moving. Factor scores are broadly constructive: EPS momentum over 30 days ranks in the 94th percentile, analyst recommendation differential in the 92nd, and the short score rank in the 85th. The drag remains valuation, with the value factor well below average. Q3 earnings are scheduled for November 25, giving the stock nine weeks of open water. Between now and then, the variables to track are whether AMD's sharp outperformance persists and narrows the relative valuation gap, how the Hugging Face integration begins to show up in guidance language, and whether any further large discretionary insider selling files through EDGAR.